Twelve Bio Company
Twelve Bio is a developer of CRISPR-Cas12a diagnostic technology can detect and change any DNA sequence.
Industry:
AI
Headquarters:
Copenhagen, Hovedstaden, Denmark
Founded Date:
01.01.2019
Employees Number:
1-10
Funding Status:
M&A
Total Funding:
519000
Estimated Revenue:
Less than $1M
Last Funding Date:
01.11.2019
Last Funding Type:
Grant
Register and Claim Ownership